HLA-C and neoplasm: In similar experiments using other tumor cell clones of the GR9 tumor system with different MHC-I expressions (A7-MHC+++, B7-MHC++, C5-MHC+), all of the tumor clones were totally immune rejected by hosts previously inoculated with Fhit-transfected tumor cells (Figure 5B).